Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

This trend runs counter to efforts promoting “active surveillance” of prostate cancers in men where treatment would ...

In a study of US veterans, the authors say many would benefit from conservative management and active surveillance over ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

In the active surveillance era, overtreatment of men with limited life expectancy (LE) decreased for those with low-risk ...

THURSDAY, Nov. 7, 2024 (HealthDay News) -- Men who undergo prostate cancer treatment face a greatly increased risk of ...

Reduction of myeloid-derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment - (https://onlinelibrary.wiley.com/doi/10.1002/ctm2.70048) ...

Clinicians must appropriately assess life expectancy and take steps to avoid prostate cancer overtreatment. Even in the active surveillance era, overtreatment persists among men with limited life ...

“Use of active surveillance has increased over the last 15 years for men with low-risk prostate cancer, and it is now the most common treatment for these men,” Daskivich said. “This approach ...

THURSDAY, Nov. 7, 2024 (HealthDay News) -- Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new study finds. Surgery for ...